Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8296900.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Eleven panic disorder patients who panicked in response to exogenous cholecystokinin tetrapeptide (CCK-4) were rechallenged after chronic treatment with imipramine. In the rechallenge the patients displayed a marked reduction in the number and intensity of panic symptoms, duration of symptoms, frequency of panic attacks, and cardiovascular responsiveness. This study demonstrates that imipramine can antagonize the panicogenic effects of CCK-4.
Medical subject headings
- Imipramine
- Panic Disorder
- Tetragastrin